Clinical guide · Endocrine
Inpatient hyperglycemia
A practical bedside approach to managing high blood glucose on the ward: what to rule out, how to dose insulin for eating vs NPO patients, and when to escalate.
Initial steps
- Rule out DKA or HHS
- Identify and treat underlying cause (infection, medications, nutrition)
- Check HbA1c if not done in the last 3 months
- Adjust diet to consistent carbohydrate plan
- Hold oral agents:
- Stop metformin and sulfonylureas
- Hold SGLT2 inhibitors unless HF indication and patient is stable
Causes of hyperglycemia in inpatients
| Medications | Glucocorticoids, fluoroquinolones, beta blockers, thiazide and loop diuretics, heparin, calcineurin inhibitors, tricyclic antidepressants, antipsychotics, lithium, HIV-protease inhibitors, levothyroxine, estrogens, sympathomimetics, nicotinic acid. |
| Pancreatic disorders | Acute or chronic pancreatitis, hemochromatosis, cystic fibrosis, pancreatic cancer, glucagonoma. |
| Endocrine disorders | Type 1 or Type 2 diabetes mellitus, gestational diabetes, hyperthyroidism, PCOS, primary hypercortisolism (adrenal adenoma, carcinoma, macronodular hyperplasia), secondary hypercortisolism (pituitary adenoma, small cell lung cancer, renal cell carcinoma), acromegaly, pheochromocytoma. |
| Stress-related | Sepsis, trauma, recent surgery. |
Patients eating a normal diet
Type 1 DM (or insulin-treated Type 2 / new hyperglycemia)
- Continue outpatient insulin regimen if glucose well controlled
- Consider 25–50% dose reduction (intake usually more restricted inpatient)
Type 2 DM (not on insulin: diet, oral agents, or GLP-1)
- Continue outpatient regimen if glucose well controlled and no contraindications
- Be cautious with metformin and sulfonylureas
- If BG poorly controlled → discontinue outpatient regimen, start insulin
Basal insulin
- Continue home dose or start 0.2–0.3 units / kg / day
- NPH q12h, detemir q12–24h, or glargine q24h
+ Prandial insulin
- Continue home dose or start 0.05–0.1 units / kg / meal
- Insulin lispro, aspart, glulisine, or regular insulin
+ Correction insulin
- For BG ≥ 8.3 mmol/L (150 mg/dL)
- Graded scale 1–4 units per 2.8 mmol/L increment above target, based on insulin sensitivity
- Use same insulin type as prandial (add to it)
If BG remains uncontrolled
- Adjust basal insulin by 10–20% every 2–3 days
- Adjust prandial / correctional insulin by 1–2 units / dose every 1–2 days
Patients who are NPO or intake is uncertain
Type 1 DM (or insulin-treated Type 2 / new hyperglycemia)
- Basal insulin: continue home dose or start 0.2–0.3 units / kg / day
- NPH q12h, detemir q12–24h, or glargine q24h
- Correction insulin for BG > 8.3 mmol/L
- Graded scale: 1–4 units per 2.8 mmol/L increment
- Regular insulin q6h
Type 2 DM (not on insulin)
- Stop oral agents
- Start correction insulin for BG > 8.3 mmol/L (same graded scale, regular insulin q6h)
If BG remains uncontrolled
- Type 1 DM: adjust basal by 10–20% every 2–3 days, adjust correction scale as above
- Type 2 DM: add basal insulin (0.2–0.3 units / kg / day) and adjust as above
- If still uncontrolled → consider IV insulin infusion
Glycemic targets
- Non-critically ill: 5.5–10 mmol/L
- Critically ill: 7.8–10 mmol/L
- Accept ≤ 11 mmol/L in frail or terminally ill patients
Insulin regimens
- Non-critically ill
- If eating: basal-bolus (basal + mealtime + correctional insulin)
- If NPO / poor intake: basal + correctional insulin (no scheduled bolus)
- Avoid sliding scale insulin alone (except short-term use)
- Critically ill
- Continuous IV insulin infusion preferred
- Transition to basal-bolus when stable
- Steroid-induced hyperglycemia
- Basal-bolus regimen
- If on prednisone / prednisolone: consider NPH-based regimen
- If on dexamethasone: longer-acting basal
Monitoring
- NPO or continuous feeds: every 4–6 h
- Eating: before meals and at bedtime
- IV insulin: every 1–2 h
- BMP: every 1–2 days (renal function, electrolytes)
- Have hypoglycemia protocol ready (treat BG < 4 mmol/L)
Special situations
- Enteral / parenteral feeding: add regular insulin to PN bag or use scheduled basal + correctional
- Insulin pumps: continue if patient is capable and appropriate
- Seek endocrine consult if glucose remains difficult to control
Summary algorithm
- Check BG
- BG > 7.8 mmol/L = inpatient hyperglycemia → monitor, address cause
- If ≥ 10 mmol/L persistently (two readings, ward or ICU) → initiate insulin
- Choose regimen: basal-bolus if eating, basal + correctional if NPO
- Target: 5.5–10 mmol/L (ward), 7.8–10 mmol/L (ICU)
- Reassess daily and adjust
Related
Last clinically reviewed · August 2026 · Last updated · August 2026